MarketBeat Instant News Alerts 2 hours agoNIKE (NYSE:NKE) Given New $50.00 Price Target at BTIG ResearchMarketBeatBTIG Research dropped their price target on NIKE from $55.00 to $50.00 and set a "buy" rating on the stock in a report on Friday.NYSE:NKERead NIKE (NYSE:NKE) Given New $50.00 Price Target at BTIG Research2 hours agoonsemi (NASDAQ:ON) Stock Keeps "Buy" Rating at Needham & Company LLCMarketBeatNeedham & Company LLC reaffirmed a "buy" rating and set a $116.00 price objective on shares of onsemi in a report on Friday.NASDAQ:ONRead onsemi (NASDAQ:ON) Stock Keeps "Buy" Rating at Needham & Company LLC2 hours agoAbbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co RedburnMarketBeatRothschild & Co Redburn upgraded shares of Abbott Laboratories from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $119.00 to $127.00 in a research report on Friday.NYSE:ABTRead Abbott Laboratories (NYSE:ABT) Upgraded to "Buy" at Rothschild & Co Redburn2 hours agoBTIG Research Reaffirms "Buy" Rating for ServiceTitan (NASDAQ:TTAN)MarketBeatBTIG Research reaffirmed a "buy" rating and set a $110.00 price objective on shares of ServiceTitan in a research report on Friday.NASDAQ:TTANRead BTIG Research Reaffirms "Buy" Rating for ServiceTitan (NASDAQ:TTAN)2 hours agoLSI Industries (NASDAQ:LYTS) Earns Buy Rating from HC WainwrightMarketBeatHC Wainwright reaffirmed a "buy" rating and issued a $30.00 price objective on shares of LSI Industries in a research note on Friday.NASDAQ:LYTSRead LSI Industries (NASDAQ:LYTS) Earns Buy Rating from HC Wainwright2 hours agoAccenture (NYSE:ACN) Price Target Raised to $195.00MarketBeatMorgan Stanley raised their price objective on shares of Accenture from $175.00 to $195.00 and gave the company an "equal weight" rating in a research report on Friday.NYSE:ACNRead Accenture (NYSE:ACN) Price Target Raised to $195.00 Trending News1Rivian Eyes Late-Year Autonomy Rollout as R2 Production Ramp Takes Center Stage2Aurora Innovation (NASDAQ:AUR) Shares Down 6.7% - Here's Why3Intel (NASDAQ:INTC) Shares Down 5.7% - Here's Why4QuantumScape (NYSE:QS) Shares Down 6.4% - Here's What Happened5USA Rare Earth (NASDAQ:USAR) Stock Price Down 5% - Here's What Happened6Rocket Lab (NASDAQ:RKLB) Stock Jumps 6.2% - Here's Why7IREN (NASDAQ:IREN) Stock Falls 1.2% on Analyst Downgrade8Oracle (NYSE:ORCL) Stock Rating Reaffirmed as Buy by Sanford C. Bernstein All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 5 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Corporate Event Transcript Dividend Earnings Earnings Preview Earnings Transcript Highlights Estimates Guidance Insider Trade Lockup Expiration MarketBeat List Articles Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoConnect Biopharma's (CNTB) "Buy" Rating Reiterated at HC WainwrightMarketBeatNASDAQ:CNTBRead Connect Biopharma's (CNTB) "Buy" Rating Reiterated at HC Wainwright2 hours agoAnadarko Petroleum (NASDAQ:APC) Raised to "Outperform" at MizuhoMarketBeatNASDAQ:APCRead Anadarko Petroleum (NASDAQ:APC) Raised to "Outperform" at Mizuho2 hours agoCullinan Therapeutics' (CGEM) "Buy" Rating Reiterated at HC WainwrightMarketBeatNASDAQ:CGEMRead Cullinan Therapeutics' (CGEM) "Buy" Rating Reiterated at HC Wainwright2 hours agoShattuck Labs (NASDAQ:STTK) Stock Price Expected to Rise, Needham & Company LLC Analyst SaysMarketBeatNASDAQ:STTKRead Shattuck Labs (NASDAQ:STTK) Stock Price Expected to Rise, Needham & Company LLC Analyst Says2 hours agoHC Wainwright Cuts Liquidia (NASDAQ:LQDA) Price Target to $58.00MarketBeatNASDAQ:LQDARead HC Wainwright Cuts Liquidia (NASDAQ:LQDA) Price Target to $58.002 hours agoBetter Home & Finance (NASDAQ:BETR) Upgraded at Cantor FitzgeraldMarketBeatNASDAQ:BETRRead Better Home & Finance (NASDAQ:BETR) Upgraded at Cantor Fitzgerald2 hours agoArtiva Biotherapeutics (NASDAQ:ARTV) Earns Overweight Rating from Cantor FitzgeraldMarketBeatNASDAQ:ARTVRead Artiva Biotherapeutics (NASDAQ:ARTV) Earns Overweight Rating from Cantor Fitzgerald2 hours agoBank of America Forecasts Strong Price Appreciation for XPO (NYSE:XPO) StockMarketBeatNYSE:XPORead Bank of America Forecasts Strong Price Appreciation for XPO (NYSE:XPO) Stock2 hours agoMarathon Petroleum (NYSE:MPC) Price Target Raised to $426.00MarketBeatNYSE:MPCRead Marathon Petroleum (NYSE:MPC) Price Target Raised to $426.002 hours agoValero Energy (NYSE:VLO) Stock Price Expected to Rise, Bank of America Analyst SaysMarketBeatNYSE:VLORead Valero Energy (NYSE:VLO) Stock Price Expected to Rise, Bank of America Analyst Says2 hours agoMongoDB's (MDB) Overweight Rating Reiterated at Cantor FitzgeraldMarketBeatNASDAQ:MDBRead MongoDB's (MDB) Overweight Rating Reiterated at Cantor Fitzgerald2 hours agoHC Wainwright Cuts Foghorn Therapeutics (NASDAQ:FHTX) Price Target to $5.00MarketBeatNASDAQ:FHTXRead HC Wainwright Cuts Foghorn Therapeutics (NASDAQ:FHTX) Price Target to $5.002 hours agoNektar Therapeutics' (NKTR) Buy Rating Reaffirmed at HC WainwrightMarketBeatNASDAQ:NKTRRead Nektar Therapeutics' (NKTR) Buy Rating Reaffirmed at HC Wainwright2 hours agoStifel Nicolaus Cuts NIKE (NYSE:NKE) Price Target to $36.00MarketBeatNYSE:NKERead Stifel Nicolaus Cuts NIKE (NYSE:NKE) Price Target to $36.002 hours agoMcCormick & Company, Incorporated (NYSE:MKC) Given New $48.00 Price Target at Stifel NicolausMarketBeatNYSE:MKCRead McCormick & Company, Incorporated (NYSE:MKC) Given New $48.00 Price Target at Stifel Nicolaus2 hours agoCPB (NYSE:CPF) Stock Picked Up by Analysts at Hovde GroupMarketBeatNYSE:CPFRead CPB (NYSE:CPF) Stock Picked Up by Analysts at Hovde Group2 hours agoRobert W. Baird Issues Positive Forecast for Block (NYSE:XYZ) Stock PriceMarketBeatNYSE:XYZRead Robert W. Baird Issues Positive Forecast for Block (NYSE:XYZ) Stock Price2 hours agoDutch Bros (NYSE:BROS) Stock Price Target Cut by Robert W. BairdMarketBeatNYSE:BROSRead Dutch Bros (NYSE:BROS) Stock Price Target Cut by Robert W. Baird2 hours agoRobert W. Baird Has Lowered Expectations for NIKE (NYSE:NKE) Stock PriceMarketBeatNYSE:NKERead Robert W. Baird Has Lowered Expectations for NIKE (NYSE:NKE) Stock Price2 hours agoOcular Therapeutix's (OCUL) "Buy" Rating Reaffirmed at Chardan CapitalMarketBeatNASDAQ:OCULRead Ocular Therapeutix's (OCUL) "Buy" Rating Reaffirmed at Chardan Capital2 hours agoSmartstop Self Storage REIT (NYSE:SMA) Stock Price Target Cut by Robert W. BairdMarketBeatNYSE:SMARead Smartstop Self Storage REIT (NYSE:SMA) Stock Price Target Cut by Robert W. Baird2 hours agoClene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 DecisionMarketBeatNASDAQ:CLNNRead Clene Targets Q4 FDA Filing for ALS Drug CNM-Au8, Eyes Mid-2027 Decision2 hours agoWhat is Sidoti's Estimate for NeoVolta Q1 Earnings?MarketBeatNASDAQ:NEOVRead What is Sidoti's Estimate for NeoVolta Q1 Earnings?2 hours agoAnalysts Issue Forecasts for Spire's Q4 Earnings (NYSE:SR)MarketBeatNYSE:SRRead Analysts Issue Forecasts for Spire's Q4 Earnings (NYSE:SR) Featured Articles and OffersDeutsche Bank Makes a Contrarian Call on Netflix—What Does It Mean for Investors?By Sam Quirke | September 30, 2026The only 5 stocks that matterFrom TradeSmith (Ad)Six Flags Launches FlexPay—Is There Any FUN Left in the Stock?By Chris Markoch | September 28, 2026Data Centers Got the AI Hype—But Office REITs May Get the Rent HikesBy Chris Markoch | September 27, 2026CarMax Just Gave Investors a Better Reason to Believe in the TurnaroundBy Thomas Hughes | September 29, 2026Elon Musk’s Hushed FCC Filing. Dec 8th.From Paradigm Press (Ad)Oracle’s Force Majeure Notice Exposes a Bigger Problem for the AI Build-OutBy Thomas Hughes | September 29, 2026Everyone in AI Is Quietly Copying Palantir's PlaybookBy Chris Markoch | October 1, 2026 Alert CategoriesAll AlertsAnalystCongressional TradesConsensusCorporate BuybackCorporate Event TranscriptStock ListDividendEarningsEarnings PreviewEarnings Transcript HighlightsEstimatesGuidanceInsider TradeLockup ExpirationMarketBeat List ArticlesOptionsPriceSEC FilingStock Split Page 1 of 186 1234567 Earlier › Earliest » Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
